ASX - By Stock
|
BGT Biotech |
Re:
BioGene Media
|
|
R-7
|
102 |
36K |
8 |
07/10/22 |
07/10/22 |
ASX - By Stock
|
102
|
36K
|
8
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Quarterly Activities Report and Appendix 4C
|
|
R-7
|
17 |
7.7K |
10 |
31/07/22 |
31/07/22 |
ASX - By Stock
|
17
|
7.7K
|
10
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Strategic Placement of $1.5 million to Cornerstone Investor
|
|
R-7
|
107 |
28K |
5 |
15/03/22 |
15/03/22 |
ASX - By Stock
|
107
|
28K
|
5
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Positive Stored Grain Pest Results
|
|
R-7
|
77 |
16K |
11 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
77
|
16K
|
11
|
|
ASX - By Stock
|
SMN |
Re:
Ann: Breakthrough FAA Certification
|
|
R-7
|
341 |
91K |
14 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
341
|
91K
|
14
|
|
ASX - By Stock
|
SMN |
Re:
Ann: Breakthrough FAA Certification
|
|
R-7
|
341 |
91K |
16 |
07/03/22 |
07/03/22 |
ASX - By Stock
|
341
|
91K
|
16
|
|
ASX - By Stock
|
TYP |
Re:
codiak share price
|
|
R-7
|
18 |
5.2K |
10 |
29/01/22 |
29/01/22 |
ASX - By Stock
|
18
|
5.2K
|
10
|
|
ASX - By Stock
|
TYP |
Re:
codiak share price
|
|
R-7
|
18 |
5.2K |
11 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
18
|
5.2K
|
11
|
|
ASX - By Stock
|
TYP |
Re:
codiak share price
|
|
R-7
|
18 |
5.2K |
4 |
27/01/22 |
27/01/22 |
ASX - By Stock
|
18
|
5.2K
|
4
|
|
ASX - By Stock
|
TYP |
Re:
codiak share price
|
|
R-7
|
18 |
5.2K |
4 |
26/01/22 |
26/01/22 |
ASX - By Stock
|
18
|
5.2K
|
4
|
|
ASX - By Stock
|
TYP |
Re:
Why did we invest in This company
|
|
R-7
|
2 |
1.1K |
10 |
16/01/22 |
16/01/22 |
ASX - By Stock
|
2
|
1.1K
|
10
|
|
ASX - By Stock
|
K2F |
Re:
Ann: K2F Contracts with Rio Tinto to implement Ground Disturbance
|
|
R-7
|
36 |
12K |
16 |
05/10/21 |
05/10/21 |
ASX - By Stock
|
36
|
12K
|
16
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Exopharm LEAP Technology - Further Step Towards US Patent
|
|
R-7
|
19 |
8.5K |
9 |
30/09/21 |
30/09/21 |
ASX - By Stock
|
19
|
8.5K
|
9
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Exopharm LEAP Technology - Further Step Towards US Patent
|
|
R-7
|
19 |
8.5K |
15 |
29/09/21 |
29/09/21 |
ASX - By Stock
|
19
|
8.5K
|
15
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Exopharm LEAP Technology - Further Step Towards US Patent
|
|
R-7
|
19 |
8.5K |
7 |
28/09/21 |
28/09/21 |
ASX - By Stock
|
19
|
8.5K
|
7
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Exopharm LEAP Technology - Second Commercial Collaboration
|
|
R-7
|
76 |
23K |
3 |
23/09/21 |
23/09/21 |
ASX - By Stock
|
76
|
23K
|
3
|
|
ASX - By Stock
|
K2F |
Re:
Ann: K2fly Extends SaaS Solution with Newmont for 5 years
|
|
R-7
|
17 |
5.0K |
5 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
17
|
5.0K
|
5
|
|
ASX - By Stock
|
K2F |
Re:
Ann: K2fly Extends SaaS Solution with Newmont for 5 years
|
|
R-7
|
17 |
5.0K |
5 |
17/09/21 |
17/09/21 |
ASX - By Stock
|
17
|
5.0K
|
5
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Exopharm LEAP Technology - Second Commercial Collaboration
|
|
R-7
|
76 |
23K |
12 |
10/09/21 |
10/09/21 |
ASX - By Stock
|
76
|
23K
|
12
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Exopharm LEAP Technology - Second Commercial Collaboration
|
|
R-7
|
76 |
23K |
10 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
76
|
23K
|
10
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Exopharm LEAP Technology - Second Commercial Collaboration
|
|
R-7
|
76 |
23K |
24 |
09/09/21 |
09/09/21 |
ASX - By Stock
|
76
|
23K
|
24
|
|
ASX - By Stock
|
SMN |
Re:
Ann: Trading Halt
|
|
R-7
|
36 |
11K |
11 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
36
|
11K
|
11
|
|
ASX - By Stock
|
SMN |
Re:
Ann: Trading Halt
|
|
R-7
|
36 |
11K |
6 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
36
|
11K
|
6
|
|
ASX - By Stock
|
SMN |
Re:
Ann: Trading Halt
|
|
R-7
|
36 |
11K |
1 |
01/09/21 |
01/09/21 |
ASX - By Stock
|
36
|
11K
|
1
|
|
ASX - By Stock
|
TYP |
Re:
update webinar now at 10:30am AEST
|
|
R-7
|
8 |
4.0K |
7 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
8
|
4.0K
|
7
|
|
ASX - By Stock
|
M3M |
Re:
IPO M3M- Capital Structure
|
|
R-7
|
5 |
2.8K |
2 |
08/07/21 |
08/07/21 |
ASX - By Stock
|
5
|
2.8K
|
2
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Exopharm Shareholder Update - Revenue Focus in 2021
|
|
R-7
|
153 |
62K |
0 |
03/06/21 |
03/06/21 |
ASX - By Stock
|
153
|
62K
|
0
|
|
ASX - By Stock
|
K2F |
Re:
Ann: Becoming a substantial holder
|
|
R-7
|
3 |
1.4K |
7 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
3
|
1.4K
|
7
|
|
ASX - By Stock
|
TYP |
Re:
What's the difference?
|
|
R-7
|
2 |
1.4K |
6 |
02/05/21 |
02/05/21 |
ASX - By Stock
|
2
|
1.4K
|
6
|
|
ASX - By Stock
|
K2F |
Re:
Ann: Becoming a substantial holder
|
|
R-7
|
10 |
2.7K |
2 |
01/05/21 |
01/05/21 |
ASX - By Stock
|
10
|
2.7K
|
2
|
|
ASX - By Stock
|
K2F |
Re:
Ann: K2F Quarterly Activities Report
|
|
R-7
|
10 |
3.2K |
10 |
27/04/21 |
27/04/21 |
ASX - By Stock
|
10
|
3.2K
|
10
|
|
ASX - By Stock
|
TYP |
Re:
Ann: Exopharm Receives Firm Commitments to Raise $12 million
|
|
R-7
|
41 |
18K |
21 |
23/04/21 |
23/04/21 |
ASX - By Stock
|
41
|
18K
|
21
|
|
ASX - By Stock
|
TYP |
Re:
Exopharm on Channel 7 news tonight!
|
|
R-7
|
46 |
17K |
12 |
20/03/21 |
20/03/21 |
ASX - By Stock
|
46
|
17K
|
12
|
|
ASX - By Stock
|
TYP |
Re:
Exopharm on Channel 7 news tonight!
|
|
R-7
|
46 |
17K |
18 |
13/03/21 |
13/03/21 |
ASX - By Stock
|
46
|
17K
|
18
|
|
ASX - By Stock
|
ELS |
Re:
Ann: Appendix 3G
|
|
R-7
|
2 |
817 |
1 |
12/03/21 |
12/03/21 |
ASX - By Stock
|
2
|
817
|
1
|
|
ASX - By Stock
|
ELS |
Re:
Has ELS just taken us for a Ride?
|
|
R-7
|
120 |
29K |
9 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
120
|
29K
|
9
|
|
ASX - By Stock
|
AKO |
Re:
Ann: Change in substantial holding
|
|
R-7
|
4 |
1.5K |
0 |
11/02/21 |
11/02/21 |
ASX - By Stock
|
4
|
1.5K
|
0
|
|
ASX - By Stock
|
TYP |
Re:
Value in new medicines and longer strides
|
|
R-7
|
112 |
39K |
3 |
08/02/21 |
08/02/21 |
ASX - By Stock
|
112
|
39K
|
3
|
|
ASX - By Stock
|
K2F |
Re:
Ann: Rio Tinto Heritage Management Contract with K2fly
|
|
R-7
|
15 |
4.7K |
2 |
05/02/21 |
05/02/21 |
ASX - By Stock
|
15
|
4.7K
|
2
|
|
ASX - By Stock
|
K2F |
Re:
Ann: Rio Tinto Heritage Management Contract with K2fly
|
|
R-7
|
15 |
4.7K |
17 |
04/02/21 |
04/02/21 |
ASX - By Stock
|
15
|
4.7K
|
17
|
|
ASX - By Stock
|
K2F |
Re:
Ann: K2fly to acquire Deciphers mining solutions business
|
|
R-7
|
29 |
9.7K |
7 |
02/02/21 |
02/02/21 |
ASX - By Stock
|
29
|
9.7K
|
7
|
|
ASX - By Stock
|
K2F |
Re:
Ann: K2fly to acquire Deciphers mining solutions business
|
|
R-7
|
29 |
9.7K |
16 |
01/02/21 |
01/02/21 |
ASX - By Stock
|
29
|
9.7K
|
16
|
|
ASX - By Stock
|
K2F |
Re:
K2F Profile: 70c+ share price target
|
|
R-7
|
21 |
9.1K |
3 |
11/01/21 |
11/01/21 |
ASX - By Stock
|
21
|
9.1K
|
3
|
|
ASX - By Stock
|
BGT |
Re:
Ann: 2020 Notice of Annual General Meeting/Proxy Form
|
|
R-7
|
26 |
5.7K |
11 |
03/11/20 |
03/11/20 |
ASX - By Stock
|
26
|
5.7K
|
11
|
|
ASX - By Stock
|
K2F |
Re:
Ann: Trading Halt
|
|
R-7
|
22 |
6.4K |
6 |
27/10/20 |
27/10/20 |
ASX - By Stock
|
22
|
6.4K
|
6
|
|
ASX - By Stock
|
K2F |
Re:
Ann: Trading Halt
|
|
R-7
|
22 |
6.4K |
7 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
22
|
6.4K
|
7
|
|
ASX - By Stock
|
K2F |
Re:
Ann: Trading Halt
|
|
R-7
|
22 |
6.4K |
8 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
22
|
6.4K
|
8
|
|
ASX - By Stock
|
K2F |
Re:
Ann: Trading Halt
|
|
R-7
|
22 |
6.4K |
7 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
22
|
6.4K
|
7
|
|
ASX - By Stock
|
K2F |
Re:
Ann: Trading Halt
|
|
R-7
|
22 |
6.4K |
9 |
26/10/20 |
26/10/20 |
ASX - By Stock
|
22
|
6.4K
|
9
|
|
ASX - By Stock
|
BGT |
Re:
Ann: Update - Non-executive Director Kevin Rumble
|
|
R-7
|
17 |
4.4K |
2 |
26/09/20 |
26/09/20 |
ASX - By Stock
|
17
|
4.4K
|
2
|
|